A herpesvirus antigen in human premalignant and malignant cervical biopsies and explants.
Cervical biopsies and explant cultures from patients with squamous metaplasia, various grades of dysplasia, carcinoma in situ (CIS), and invasive squamous cell carcinoma were screened for VP143, an early nonstructural polypeptide of herpes simplex virus type 2 (HSV-2), VP143 was identified in 31% of biopsies exhibiting severe dysplasia, 29% with CIS, and 41% with invasive squamous cell carcinoma. Similar results were obtained when explants derived from these biopsies were examined for VP143. The expression of the protein persisted in passaged subcultures in four of five invasive carcinomas which originally contained VP143. Staining for VP157, the major capsid protein of HSV-2, was absent. Furthermore, virus structures were not seen by electron microscopy and infectious virus was not isolated from cell cultures inoculated with biopsy extracts. These results suggest that VP143 was expressed in the premalignant and malignant cervical cells in the absence of productive viral infection. Thus, a fragment of the HSV-2 genome was retained within the cells, the expression of which resulted in the production of VP143.
D000956:Antigens, Viral / Q000276:immunology*; D000957:Antigens, Viral, Tumor; D001706:Biopsy; D002278:Carcinoma in Situ / Q000209:etiology*; D002294:Carcinoma, Squamous Cell / Q000209:etiology*; D002478:Cells, Cultured; D002584:Cervix Uteri / Q000276:immunology; D003584:Cytological Techniques; D005260:Female; D006801:Humans; D007124:Immunoenzyme Techniques; D008854:Microscopy, Electron; D018139:Simplexvirus / Q000276:immunology*; D002578:Uterine Cervical Dysplasia / Q000209:etiology; D002583:Uterine Cervical Neoplasms / Q000276:immunology* / Q000556:secondary / Q000648:ultrastructure; D002575:Uterine Cervicitis / Q000209:etiology*
D000956:Antigens, Viral; D000957:Antigens, Viral, Tumor; C036797:VP 143